Results for "equate"

Equate Infant’s Pain & Fever Acetaminophen

November 5th, 2020

In August 2020, a class-action lawsuit was filed against Perrigo Company and Walmart for allegedly misleadingly marketing that Equate Infant’s Pain & Fever Acetaminophen is formulated specifically for infants and charging more for the infants’ product than Equate Children’s Pain & Fever Acetaminophen Oral Suspension when, according to the complaint, the products contain the same


Equate Infant’s and Children’s Pain & Fever Acetaminophen

August 21st, 2020

In June 2020, a class-action lawsuit was filed alleging that Walmart misleads consumers by marketing Equate™ Infant’s Pain & Fever Acetaminophen and Equate™ Children’s Pain & Fever Acetaminophen as different products and charging more for the Infants’ medication when, according to plaintiffs, the products contain the same amount of the active ingredient acetaminophen and are


Equate™ Rapid Release Products

July 31st, 2020

April 2019: A federal judge dismissed certain claims but allowed the false advertising claims to move forward. November 2018: A class-action lawsuit was filed against Walmart for allegedly misleadingly marketing its Equate™ Rapid Release products as being comparable to Tylenol® Extra Strength Rapid Release Gels when, according to plaintiffs, the Tylenol® products have “unique laser


Equate High Absorption CoQ-10

January 24th, 2019

December 2017: This case was voluntarily dismissed , the reasons for which have not been disclosed. The plaintiff also agreed not to refile a similar complaint until the earlier of 90 days after the dismissal or the date the settlement in Jackson v. Lang Pharma Nutrition fails. August 2017: A class-action lawsuit was filed against


Equate Migraine

June 7th, 2018

December 2013: This case was voluntarily dismissed , the reasons for which have not been disclosed. October 2013: A class-action lawsuit was filed against Walmart for allegedly falsely marketing Equate Extra Strength Headache Relief and Equate Migraine Relief. Specifically, the complaint alleges that the company falsely markets Equate Migraine as a “superior and more-potent drug


Walmart’s Equate Migraine

April 27th, 2018

April 2016: The Ninth Circuit Court of Appeals affirmed the dismissal concluding that the complaint failed to state a claim upon which relief could be granted. (Case No. 14-55752, 9th Cir.) May 2014: Because plaintiffs did not file an amended complaint after their case was dismissed , the case was dismissed . Later in May,


Equate Migraine Pain Reliever

April 27th, 2018

December 2013: This case was voluntarily dismissed , the reasons for which have not been disclosed. September 2013: A class-action lawsuit was filed against Walmart for allegedly deceptively marketing the over-the-counter pain reliever Equate Migraine Pain Reliever. Specifically, plaintiffs claim that Walmart promotes Equate Migraine as a stronger medicine than Equate Headache that will more


Walmart’s Equate Co-Q10

December 14th, 2017

September 2016: A federal judge granted the named plaintiff’s motion to voluntarily dismiss this action and imposed two conditions on the dismissal: First, the named plaintiff must agree to use the discovery from this case in a state court case; and second, the named plaintiff must be deposed. The dismissal was . April 2015: The


Equate Flushable Wipes

July 25th, 2017

January 2017: This action was dismissed , the reasons for which have not been disclosed. August 2015: A class-action lawsuit was filed against Walmart and Rockline Industries for allegedly misleadingly marketing Equate Flushable Wipes as “flushable” and “safe for properly maintained septic and sewer systems” when, according to the complaint, the wipes cause many plumbing


Walmart Equate Migraine

July 1st, 2014

April 2016: The Ninth Circuit Court of Appeals affirmed the district court’s dismissal concluding that the complaint failed to state a claim. May 2014: A federal judge dismissed a class-action lawsuit against Walmart because plaintiffs did not file an amended complaint fixing the problems in the earlier complaint, as required by a court order. The


Tecate Beer

December 2nd, 2020

In November 2020, a class-action lawsuit was filed against Heineken USA Inc. for allegedly misleadingly advertising Tecate brand beer as a Mexican beer without adequately disclosing that the beer is brewed in Holland. (Schelmetty et al v. Heineken USA Inc., Case No. 20-cv-9985, S.D.N.Y.) For more of TINA.org’s coverage of alcohol, click here.


Jimmy John’s Cookies

December 2nd, 2020

November 2020: This case was transferred from state court to federal court. (Case No. 20-cv-1268, S.D. Ill.) October 2020: A class-action lawsuit was filed against Jimmy John’s for allegedly falsely advertising its Triple Chocolate Chunk Cookie and Raisin Oatmeal Cookie as “All Natural” without adequately disclosing that the cookies contain highly processed and artificial ingredients.


Trulia

November 20th, 2020

In November 2019, a class-action lawsuit was filed against Trulia, LLC for allegedly deceiving consumers and violating the law by failing to adequately disclose the identity of listing agents for properties listed for sale on its website. According to the complaint, the website connects prospective homebuyers with Trulia’s “Premier Agents” – i.e., agents who have


Prevagen Products

November 19th, 2020

November 2020: A federal judge granted final approval of the settlement agreement. October 2020: TINA.org filed an amicus curiae brief opposing the terms of the proposed settlement agreement as unfair to consumers. To read the brief or learn about the issues raised by TINA.org, click here. July 2020: A federal judge preliminarily approved the settlement


Quincy Bioscience’s Prevagen Supplement

November 19th, 2020

November 2020: A federal judge granted final approval of the settlement agreement. October 2020: TINA.org filed an amicus curiae brief opposing the terms of the proposed settlement agreement as unfair to consumers. To read the brief or learn about the issues raised by TINA.org, click here. July 2020: A federal judge preliminarily approved the settlement


Prevagen Supplement

November 19th, 2020

November 2020: A federal judge granted final approval of the settlement agreement. October 2020: TINA.org filed an amicus curiae brief opposing the terms of the proposed settlement agreement as unfair to consumers. To read the brief or learn about the issues raised by TINA.org, click here. July 2020: A federal judge preliminarily approved the settlement


Prevagen Dietary Supplements

November 19th, 2020

November 2020: A federal judge granted final approval of the settlement agreement. October 2020: TINA.org filed an amicus curiae brief opposing the terms of the proposed settlement agreement as unfair to consumers. To read the brief or learn about the issues raised by TINA.org, click here. July 2020: A federal judge preliminarily approved the settlement


Prevagen Dietary Supplement

November 19th, 2020

November 2020: A federal judge granted final approval of the settlement agreement. October 2020: TINA.org filed an amicus curiae brief opposing the terms of the proposed settlement agreement as unfair to consumers. To read the brief or learn about the issues raised by TINA.org, click here. July 2020: A federal judge preliminarily approved the settlement


Quincy Bioscience’s Prevagen

November 19th, 2020

November 2020: A federal judge granted final approval of the settlement agreement. October 2020: TINA.org filed an amicus curiae brief opposing the terms of the proposed settlement agreement as unfair to consumers. To read the brief or learn about the issues raised by TINA.org, click here. July 2020: A federal judge preliminarily approved the settlement


Promotions on Boxes of Eggo Waffles, Pop Tarts, and Kellogg’s Cereals

November 17th, 2020

In November 2020, a class-action lawsuit was filed against Kellogg Company for allegedly misleadingly offering promotions for money off of crayons, snacks at the movies, and movie tickets on boxes of Eggo Waffles, Pop Tarts, and Kellogg’s cereals without adequately disclosing that the promotions end before the products expire. (Seaman et al v. Kellogg Company,



Back to Top ↑